For this reason, we performed a systematic review and network meta-analysis to compare and rank the efficacy and safety of different ICIs plus chemotherapy for patients with ESCC, and to decide on the best treatment for patients grouped according to clinically relevant subgroups, such as gender, age, and PD-L1 expression. Here, CD274 is linked to esophageal squamous cell carcinoma.